Abstract：The picornaviridae is the smallest group of RNA virus, which can cause human and animal diseases. The 3C protein is an important non-structural protein of the picornavirus. This paper reviews recent advances in 3C proteins, including the functions of promoting viral replication, affecting apoptosis and evading host immune response, which provides a theoretical basis and a new solution for the prevention and control of picornavirus infection.
曹圣慧, 黄孝天. 小RNA病毒3C蛋白功能的研究进展[J]. 中国人兽共患病学报, 2019, 35(12): 1130-1133.
CAO Sheng-hui, HUANG Xiao-tian. Research Progress on the function of picornavirus 3C protein. Chinese Journal of Zoonoses, 2019, 35(12): 1130-1133.
[1] Zell R, Delwart E, Gorbalenya AE, et al.ICTV virus taxonomy profile: picornaviridae[J]. J Gen Virol, 2017, 98(10):2421-2422. DOI:10.1099/jgv.0.000911 [2] Bedard KM, Semler BL.Regulation of picornavirus gene expression[J]. Microbes Infect, 2004, 6(7):702-713. DOI:10.1016/j.micinf.2004.03.001 [3] Koh WM, Badaruddin H, La H, et al.Severity and burden of hand, foot and mouth disease in Asia: a modelling study[J]. BMJ Global Health, 2018, 3(1):e000442. DOI:10.1136/bmjgh-2017-000442 [4] Bissel SJ, Winkler CC, Deltondo J, et al.Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins[J]. Neuropathology, 2014, 34(5):429-437. DOI: 10.1111/neup.12121 [5] Esposito S, Bosis S, Niesters H,et al.Enterovirus D68 Infection[J]. Viruses, 2015, 7(11): 6043-6050. DOI:10.3390/v7112925 [6] Knight-Jones TJD, Rushton J.The economic impacts of foot and mouth disease-What are they, how big are they and where do they occur[J]. Prev Vet Med, 2013, 112(3/4):161-173. DOI:10.1016/j.prevetmed.2013.07.013 [7] Carocci M, Bakkali-Kassimi L.The encephalomyocarditis virus[J]. Virulence, 2012, 3(4):351-367. DOI:10.4161/viru.20573 [8] Wang J, Fan T, Yao X, et al.Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues[J]. J Virol, 2011, 85(19):10021-10030. DOI:10.1128/jvi.05107-11 [9] Birtley JR, Knox SR, Jaulent AM, et al.Crystal structure of foot-and-mouth disease virus 3C protease: new insights into catalytic mechanism and cleavage specificity[J]. J Biol Chem, 2005, 280(12):11520-11527. DOI:10.1074/jbc.M413254200 [10] Cui S, Wang J, Fan T, et al.Crystal structure of human enterovirus 71 3C protease[J]. J Mol Biol, 2011, 408(3): 449-461. DOI:10.1016/j.jmb.2011.03.007 [11] Sun D, Wang M, Wen X, et al.Cleavage of poly(A)-binding protein by duck hepatitis A virus 3C protease[J]. Sci Rep, 2017, 7(1):16261. DOI:10.1038/s41598-017-16484-1 [12] M Kobayashi M, Arias C, Garabedian A, et al. Site-specific cleavage of the host poly(A) binding protein by the encephalomyocarditis virus 3C proteinase stimulates viral replication[J]. J Virol, 2012, 86(19): 10686-10694. DOI:10.1128/jvi.00896-12 [13] Flather D, Nguyen JHC, Semler BL,et al.Exploitation of nuclear functions by human rhinovirus, a cytoplasmic RNA virus[J]. PLoS Pathog, 2018, 14(8): e1007277.DOI:10.1371/journal.ppat.1007277 [14] Yu-Hsiu C, Seng LK, Rei-Lin K, et al.dsRNA binding domain of PKR is proteolytically released by enterovirus A71 to facilitate viral replication[J]. Front Cell Infect Microbiol, 2017, 7: 284. DOI:10.3389/fcimb.2017.00284 [15] Yao C, Xi C, Hu K, et al.Inhibition of enterovirus 71 replication and viral 3C protease by quercetin[J]. Virol J, 2018, 15(1): 116. DOI:10.1186/s12985-018-1023-6 [16] Amitava M, Morosky SA, Elizabeth DA, et al.The coxsackievirus B 3Cpro protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling[J]. PLoS Pathog, 2011, 7(3): e1001311. DOI:10.1371/journal.ppat.1001311 [17] Li ML, Hsu TA, Chen TC, et al.The 3C protease activity of enterovirus 71 induces human neural cell apoptosis[J]. Virology, 2002, 293(2): 386-395. DOI:10.1006/viro.2001.1310 [18] Fengmei S, Xiaoyan Y, Ting Z, et al.Caspase-3 Inhibition attenuates the cytopathic effects of EV71 infection[J]. Front Microbiol, 2018, 9: 817. DOI:10.3389/fmicb.2018.00817 [19] Chau DHW, Yuan J, Zhang H, et al.Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1[J]. Apoptosis, 2007, 12(3):513-524.DOI: 10.1007/s10495-006-0013-0 [20] Li J, Yao Y, Chen Y, et al. Enterovirus 71 3C promotes apoptosis through cleavage of PinX1, a telomere binding protein[J]. J Virol, 2017, 91(2):JVI.02016-16.DOI:10.1128/JVI.02016-16 [21] Croft SN, Walker EJ, Ghildyal R.Human Rhinovirus 3C protease cleaves RIPK1, concurrent with caspase 8 activation[J]. Sci Rep, 2018, 8(1): 1569. DOI:10.1038/s41598-018-19839-4 [22] Rui Y, Su J, Wang H, et al. Disruption of MDA5 mediated innate immune responses by the 3C proteins of Coxsackievirus A16, Coxsackievirus A6,Enterovirus D68[J]. J Virol, 2017, 91(13): JVI.00546-17.DOI: 10.1128/jvi.00546-17 [23] Lei X, Liu X, Ma Y, et al.The 3C protein of enterovirus 71 inhibits retinoid acid-Inducible gene I-Mediated interferon regulatory factor 3 activation and type I interferon responses[J]. J Virol, 2010, 84(16): 8051-8061. DOI:10.1128/jvi.02491-09 [24] Lei X, Xiao X, Xue Q, et al.Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses[J]. J Virol, 2013, 87(3): 1690-1698. DOI:10.1128/jvi.01855-12 [25] Lei X, Sun Z, Liu X,et al.Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3[J]. J Virol, 2011, 85(17): 8811-8818. DOI:10.1128/jvi.00447-11 [26] Lei X, Han N, Xiao X, et al.Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex[J]. J Virol, 2014, 88(17): 9830-9841. DOI:10.1128/jvi.01425-14 [27] Xiang Z, Li L, Lei X, et al.Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by toll-like receptor 3[J]. J Virol, 2014, 88(12): 6650-6659. DOI:10.1128/jvi.03138-13 [28] Huang L, Liu Q, Zhang L, et al.Encephalomyocarditis virus 3C protease relieves TRAF family member-associated NF-κB activator (TANK) Inhibitory effect on TRAF6-mediated NF-κB signaling through cleavage of TANK[J]. J Biol Chem, 2015, 290(46): 27618-27632. DOI:10.1074/jbc.M115.660761
2019, Vol. 35 
